# Repeat BCG Vaccinations For The Treatment Of Pediatric Type 1 Diabetes

> **NCT05180591** · PHASE2 · RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 1
- Diabetes type1
- Autoimmune Diabetes

## Interventions

- **BIOLOGICAL:** Bacillus Calmette-Guérin
- **BIOLOGICAL:** Saline Injection

## Key facts

- **NCT ID:** NCT05180591
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-22
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05180591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05180591, "Repeat BCG Vaccinations For The Treatment Of Pediatric Type 1 Diabetes". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT05180591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*